Clinical Trial Update: 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

View source ↗

Summary

A 10-year registry of children aged 2-17 with eczema who have used pimecrolimus; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Pimecrolimus (pimecrolimus)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Atopic Dermatitis | Status: ACTIVE_NOT_RECRUITING